Gene-Sequencing Company Illumina to Sell Cancer Test Developer

11 months ago 53

News Banner

The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.

Looking for an Interim or Fractional CTO to support your business?